A phase II/III clinical study of R442(Pegylated Interferon alfa-2a) for patients with chronic hepatitis B.

Trial Profile

A phase II/III clinical study of R442(Pegylated Interferon alfa-2a) for patients with chronic hepatitis B.

Completed
Phase of Trial: Phase II/III

Latest Information Update: 27 May 2016

At a glance

  • Drugs Peginterferon alfa-2a (Primary) ; Interferon alpha
  • Indications Hepatitis B
  • Focus Registrational; Therapeutic Use
  • Sponsors Chugai Pharmaceutical
  • Most Recent Events

    • 20 Sep 2011 Status changed from active, no longer recruiting to completed.
    • 28 Oct 2009 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
    • 15 May 2007 Status changed from initiated to recruiting
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top